A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients | Orphanet Journal of Rare Diseases | Full
Figure 1 from A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up. | Semantic Scholar
Securing market access with single-arm trial data - IQVIA
Securing market access with single-arm trial data - IQVIA
Incorporating data from single-arm studies into network meta-analyses - ppt download
fig1.jpg
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma | PLOS ONE
START: single‐to‐double arm transition design for phase II clinical trials - Shi - 2020 - Pharmaceutical Statistics - Wiley Online Library
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer | Communications Medicine
The Role of Noncomparative Evidence in Health Technology Assessment Decisions - ScienceDirect
Clinical trials are better, faster, cheaper with big data | MIT Technology Review
EXACT Trial: Results of the Phase 1 Dose-Escalation Study | Circulation: Cardiovascular Interventions
George Clinical Guides Sponsor with Limited Clinical Trial Experience in Phase II Melanoma-TIL Trial – George Clinical
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice - The Lancet Oncology
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer | Nature Communications
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial - The Lancet Infectious Diseases
Single Arm Trials for FDA Drug Approvals in Oncology – Healthcare Economist
Adaptive trial designs: what are multiarm, multistage trials? | ADC Education & Practice Edition
Securing market access with single-arm trial data - IQVIA
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial - The Lancet Oncology
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial... | Download Scientific Diagram
On Biostatistics and Clinical Trials: Synthetic Control Arm (SCA), External Control, Historical Control
Adaptive design (medicine) - Wikipedia
A Diagram of external control in single-arm trial. B Diagram of hybrid... | Download Scientific Diagram
Single arm trials in the context (era) of platforms
Frontiers | Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Basket Trials and Umbrella Trials (Chapter 8) - Introduction to Adaptive Trial Designs and Master Protocols
